the future of infection protection
fast-acting universal antivirals for disrupting respiratory infections
we live in an increasingly infectious world.
viral mutation is outpacing innovation.
respiratory infections impact everyone. we are sick of being sick.
the world’s first
fast-acting
universal antiviral
Convenient nasal spray format brings protection within reach
no
needles
prescriptions
metal mouth
rebounds
positive test required
benefits
speed
breadth
accessibility
safety
efficacy
convenience
simplicity
deadly
respiratory infections were the #4 killer globally in 2019 (W.H.O.)
and the #1 killer among children <5 years old.
disruptive
URI’s accounted for 42.8% of all illness from 1990-2019 (The Lancet).
damaging
Economists estimate that COVID-19 cost the United States $16 Trillion (JAMA).
a new approach for infection protection
stop the virus before it has a chance to take hold.
start targeting viral load where it begins:
in the nose
targeting nasal viral load works
reduces your risk of getting sick
reduces severity and time you are sick
reduces the risk of making others sick
Our candidates reduce viral load by >99.999%